(Q36648151)

15 August 2017

1 reference

title

Update on the medical treatment of juvenile idiopathic arthritis (English)

1 reference

juvenile rheumatoid arthritis

15 August 2017

1 reference

Philip J Hashkes

1

1 reference

PubMed ID

17092444

15 August 2017

Ronald M Laxer

series ordinal

2

1 reference

15 August 2017

1 December 2006

1 reference

Current Rheumatology Reports

15 August 2017

1 reference

15 August 2017

8

1 reference

15 August 2017

6

1 reference

15 August 2017

450-458

1 reference

https://scigraph.springernature.com/pub.10.1007/s11926-006-0041-3

15 August 2017

0 references

cites work

Is hydrotherapy cost-effective? A randomised controlled trial of combined hydrotherapy programmes compared with physiotherapy land techniques in children with juvenile idiopathic arthritis

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11926-006-0041-3

Tuberculosis in a nine-year-old girl treated with infliximab for systemic juvenile idiopathic arthritis.

21 January 2018

1 reference

12 December 2020

Improvements in growth parameters in children with juvenile idiopathic arthritis associated with the effect of methotrexate on disease activity

1 reference

12 December 2020

The use of low dose methotrexate in children with chronic anterior and intermediate uveitis

1 reference

12 December 2020

A randomized trial of parenteral methotrexate comparing an intermediate dose with a higher dose in children with juvenile idiopathic arthritis who failed to respond to standard doses of methotrexate

1 reference

12 December 2020

1 reference

12 December 2020

Preliminary definition of improvement in juvenile arthritis

1 reference

12 December 2020

Sulfasalazine in the treatment of juvenile chronic arthritis: a randomized, double-blind, placebo-controlled, multicenter study. Dutch Juvenile Chronic Arthritis Study Group

1 reference

12 December 2020

Utility of corticosteroid injection for temporomandibular arthritis in children with juvenile idiopathic arthritis

1 reference

12 December 2020

Etanercept treatment in patients with refractory systemic onset juvenile rheumatoid arthritis.

1 reference

12 December 2020

Methotrexate treatment in juvenile idiopathic arthritis: when is the right time to stop?

1 reference

12 December 2020

Use of infliximab in patients with systemic juvenile idiopathic arthritis refractory to etanercept.

1 reference

12 December 2020

Medical treatment of juvenile idiopathic arthritis

1 reference

12 December 2020

Efficacy of etanercept for the treatment of juvenile idiopathic arthritis according to the onset type

1 reference

12 December 2020

Methotrexate is an effective treatment for chronic uveitis associated with juvenile idiopathic arthritis.

1 reference

12 December 2020

Efficacy of repeated intravenous infusions of an anti-tumor necrosis factor alpha monoclonal antibody, infliximab, in persistently active, refractory juvenile idiopathic arthritis: results of an open-label prospective study

1 reference

12 December 2020

Drug-induced systemic lupus erythematosus associated with etanercept therapy in a child with juvenile idiopathic arthritis

1 reference

12 December 2020

Tumour necrosis factor alpha inhibitors in the treatment of childhood uveitis.

1 reference

12 December 2020

Electronically monitored adherence to medications by newly diagnosed patients with juvenile rheumatoid arthritis.

1 reference

12 December 2020

The role of subcutaneous administration of methotrexate in children with juvenile idiopathic arthritis who have failed oral methotrexate

1 reference

12 December 2020

Etanercept in children with polyarticular juvenile rheumatoid arthritis. Pediatric Rheumatology Collaborative Study Group

1 reference

12 December 2020

Low-dose methotrexate treatment for oligoarticular juvenile idiopathic arthritis nonresponsive to intra-articular corticosteroids

1 reference

12 December 2020

Autologous stem cell transplantation for refractory juvenile idiopathic arthritis: analysis of clinical effects, mortality, and transplant related morbidity

1 reference

12 December 2020

Population pharmacokinetic analysis and simulation of the time-concentration profile of etanercept in pediatric patients with juvenile rheumatoid arthritis

1 reference

12 December 2020

A randomized, placebo-controlled, double-masked clinical trial of etanercept for the treatment of uveitis associated with juvenile idiopathic arthritis

1 reference

12 December 2020

Influence of methylenetetrahydrofolate reductase polymorphisms on efficacy and toxicity of methotrexate in patients with juvenile idiopathic arthritis.

1 reference

12 December 2020

Preliminary criteria for clinical remission for select categories of juvenile idiopathic arthritis.

1 reference

12 December 2020

Leflunomide or methotrexate for juvenile rheumatoid arthritis

1 reference

12 December 2020

A randomized, double-blind clinical trial of two doses of meloxicam compared with naproxen in children with juvenile idiopathic arthritis: short- and long-term efficacy and safety results

1 reference

12 December 2020

Long-term open-label preliminary study of the safety and efficacy of leflunomide in patients with polyarticular-course juvenile rheumatoid arthritis

1 reference

12 December 2020

Outcomes of treatment with immunomodulatory therapy in patients with corticosteroid-resistant juvenile idiopathic arthritis-associated chronic iridocyclitis

1 reference

12 December 2020

Bone status over 1 yr of etanercept treatment in juvenile idiopathic arthritis

1 reference

12 December 2020

Adenosine and methotrexate polyglutamate concentrations in patients with juvenile arthritis.

1 reference

12 December 2020

Anti-tumor necrosis factor alpha blockade in the treatment of juvenile spondylarthropathy

1 reference

12 December 2020

Development and validation of a clinical index for assessment of long-term damage in juvenile idiopathic arthritis.

1 reference

12 December 2020

Thalidomide for severe systemic onset juvenile rheumatoid arthritis: A multicenter study

1 reference

12 December 2020

The German etanercept registry for treatment of juvenile idiopathic arthritis

1 reference

12 December 2020

Comparison of the intraarticular effectiveness of triamcinolone hexacetonide and triamcinolone acetonide in treatment of juvenile rheumatoid arthritis.

1 reference

12 December 2020

Effective use of the recombinant interleukin 1 receptor antagonist anakinra in therapy resistant systemic onset juvenile rheumatoid arthritis.

1 reference

12 December 2020

Growth hormone is effective in the treatment of severe growth retardation in children with juvenile chronic arthritis. Double blind placebo-controlled followup study

1 reference

12 December 2020

Etanercept and uveitis in patients with juvenile idiopathic arthritis.

1 reference

12 December 2020

Evidence-based use of methotrexate in children with rheumatic diseases: a consensus statement of the Working Groups Pediatric Rheumatology Germany (AGKJR) and Pediatric Rheumatology Austria

1 reference

12 December 2020

Clinical responsiveness of self-report functional assessment measures for children with juvenile idiopathic arthritis undergoing intraarticular corticosteroid injections

1 reference

12 December 2020

Long-term outcome of juvenile idiopathic arthritis following a placebo-controlled trial: sustained benefits of early sulfasalazine treatment

1 reference

12 December 2020

Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade

1 reference

12 December 2020

Triamcinolone acetonide and hexacetonide intra-articular treatment of symmetrical joints in juvenile idiopathic arthritis: a double-blind trial

1 reference

12 December 2020

Infliximab for juvenile idiopathic arthritis-associated uveitis

1 reference

12 December 2020

Prolonged efficacy of etanercept in refractory enthesitis-related arthritis

1 reference

12 December 2020

Efficacy of custom foot orthotics in improving pain and functional status in children with juvenile idiopathic arthritis: a randomized trial.

1 reference

12 December 2020

Guidelines for blood test monitoring of methotrexate toxicity in juvenile idiopathic arthritis.

1 reference

12 December 2020

Treatment of refractory autoimmune diseases with autologous stem cell transplantation: focus on juvenile idiopathic arthritis

1 reference

12 December 2020

Patterns of clinical remission in select categories of juvenile idiopathic arthritis.

1 reference

12 December 2020

Population pharmacokinetics of the active metabolite of leflunomide in pediatric subjects with polyarticular course juvenile rheumatoid arthritis

1 reference

12 December 2020

Therapeutic efficacy of humanized recombinant anti-interleukin-6 receptor antibody in children with systemic-onset juvenile idiopathic arthritis

1 reference

12 December 2020

Development of a standardized method of assessment of radiographs and radiographic change in juvenile idiopathic arthritis: introduction of the Dijkstra composite score

1 reference

12 December 2020

Retrospective case review of pediatric patients with uveitis treated with infliximab

1 reference

12 December 2020

10.1007/S11926-006-0041-3

Identifiers

DOI

1 reference

15 August 2017

1 reference

PubMed ID

17092444